Idexx Laboratories (IDXX) Current Assets (2009 - 2026)

Idexx Laboratories has reported Current Assets for 18 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 10.8% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 10.8% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 1.0% from the prior year.
• Current Assets was $1.5 billion for Q2 2026 at Idexx Laboratories, up from $1.5 billion in the prior quarter.
• The five-year high for Current Assets was $1.5 billion in Q2 2024, with the low at $1.0 billion in Q2 2022.
• Average Current Assets over 5 years is $1.3 billion, with a median of $1.4 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Assets soared 35.75% in 2023, then slipped 12.27% in 2025.
• Over 5 years, Current Assets stood at $1.1 billion in 2022, then jumped by 35.75% to $1.5 billion in 2023, then slipped by 6.38% to $1.4 billion in 2024, then advanced by 1.0% to $1.4 billion in 2025, then grew by 6.77% to $1.5 billion in 2026.
• The last three Current Assets figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.